KRAS mutations in ovarian low-grade endometrioid adenocarcinoma: Association with concurrent endometriosis

Human Pathology

Volumn 43, Issue 8, 2012, Pages 1177-1183

  Stewart, Colin J R ^a   Leung, Yee ^b   Walsh, Michael D ^c   Walters, Rhiannon J ^c   Young, Joanne P ^c   Buchanan, Daniel D ^c  

^a KING EDWARD MEMORIAL HOSPITAL   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

Adenocarcinoma; Endometrioid; Endometriosis; Molecular; Ovary

Indexed keywords

B RAF KINASE; K RAS PROTEIN;

ADULT; AGED; ARTICLE; CANCER GRADING; DISEASE ASSOCIATION; DISEASE SEVERITY; ENDOMETRIOID CARCINOMA; ENDOMETRIOSIS; FEMALE; GENE MUTATION; GENETIC ANALYSIS; HUMAN; MAJOR CLINICAL STUDY; OVARY ADENOCARCINOMA; OVARY ENDOMETRIOID CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, ENDOMETRIOID; DNA MUTATIONAL ANALYSIS; ENDOMETRIOSIS; FEMALE; HUMANS; MIDDLE AGED; OVARIAN NEOPLASMS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS B-RAF; RAS PROTEINS;

EID: 84863984775     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2011.10.009     Document Type: Article

References (49)

1. A. Jemal, R. Siegel, J. Xu, and E. Ward Cancer statistics, 2010 CA Cancer J Clin 60 2010 277 300
2. R.J. Kuman, and I.M. Shih Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer- shifting the paradigm Hum Pathol 42 2011 918 931
3. C. Gomez-Raposa, M. Mendiola, and J. Barriuso Molecular characterization of ovarian cancer by gene-expression profiling Gynecol Oncol 118 2010 88 92
4. E. D'Angelo, and J. Prat Classification of ovarian carcinomas based on pathology and molecular genetics Clin Trans Oncol 12 2010 783 787
5. C.B. Gilks, and J. Prat Ovarian carcinoma pathology and genetics: recent advances Hum Pathol 40 2009 1213 1223
6. W.G. McCluggage My thoughts on and approach to the typing of ovarian carcinomas J Clin Pathol 61 2008 152 163 (Pubitemid 351218874)
7. J. Madore, F. Ren, and A. Filali-Mouhim Characterization of the molecular differences between ovarian endometrioid carcinoma and ovarian serous carcinoma J Pathol 220 2010 392 400
8. L. Catasus, E. Bussaglia, and I. Rodriguez Molecular genetic alterations in endometrioid carcinomas of the ovary: similar frequency of beta-catenin abnormalities but lower rate of microsatellite instability and PTEN alterations than in uterine endometrioid carcinomas Hum Pathol 35 2004 1360 1368 (Pubitemid 39601576)
9. J. Willner, K. Wurz, and K.H. Allison Alternate molecular genetic pathways in ovarian carcinomas of common histological types Hum Pathol 38 2007 607 613 (Pubitemid 46399888)
10. C.B. Gilks Molecular abnormalities in ovarian cancer subtypes other than high-grade serous carcinoma J Oncol 2010 10.1155/2010/740968 [Epub ahead of press].
11. K.C. Wiegand, S.P. Shah, and O.M. Al-Agha ARID1A mutations in endometriosis-associated ovarian carcinomas N Engl J Med 363 2010 1532 1543
12. B. Guan, T.L. Mao, and P.K. Panuganti Mutation and loss of expression of ARID1A in uterine low-grade endometrioid carcinoma Am J Surg Pathol 35 2011 625 632
13. N. Singh Synchronous tumours of the female genital tract Histopathology 56 2010 277 285
14. M. Wells Recent advances in endometriosis with emphasis on pathogenesis, molecular pathology, and neoplastic transformation Int J Gynecol Pathol 23 2004 316 320 (Pubitemid 39299019)
15. T. Van Gorp, F. Amant, and P. Neven Endometriosis and the development of malignant tumours of the pelvis. A review of literature Best Pract Res Clin Obstet Gynaecol 18 2004 349 371 (Pubitemid 38786637)
16. M. Mandal, K. Yamaguchi, and N. Matsumura Ovarian cancer in endometriosis: molecular biology, pathology, and clinical management Int J Clin Oncol 14 2009 383 391
17. A.H. Prowse, S. Manek, and R. Varma Molecular genetic evidence that endometriosis is a precursor of ovarian cancer Int J Cancer 119 2006 556 562 (Pubitemid 43955708)
18. P. Vigano, E. Somigliana, and I. Chiodo Molecular mechanisms and biological plausibility underlying the malignant transformation of endometriosis: a critical analysis Hum Reprod Update 12 2006 77 89 (Pubitemid 43013749)
19. D.M. Dinulescu, T.A. Ince, and B.J. Quade Role of K-RAS and PTEN in the development of mouse models of endometriosis and endometrioid ovarian cancer Nat Med 11 2005 63 70 (Pubitemid 40215839)
20. F. Prefumo, P.L. Venturini, and E. Fulcheri Analysis of p53 and c-erbB-2 expression in ovarian carcinomas arising in endometriosis Int J Gynecol Pathol 22 2003 83 88 (Pubitemid 36014281)
21. D.S. McMeekin, R.A. Burger, and A. Manetta Endometrioid adenocarcinoma of the ovary and its relationship to endometriosis Gynecol Oncol 59 1995 81 86
22. C. Banz, U. Ungethuem, and R.J. Kuban The molecular signature of endometriosis-associated endometrioid ovarian cancer differs significantly from endometriosis-independent ovarian cancer Fertil Steril 94 2010 1212 1217
23. C.J.R. Stewart, B. Brennan, and T. Chan WT1 immunohistochemistry in ovarian endometrioid carcinoma with and without endometriosis Pathology 40 2008 592 599
24. J. Prat Ovarian carcinomas, including secondary tumors: diagnostically challenging areas Mod Pathol 18 2005 S99 111
25. D.D. Buchanan, K. Sweet, and M. Drini Risk factors for colorectal cancer in patients with multiple serrated polyps: a cross-sectional case series from genetics clinics PLoS One 5 2010 e11636
26. S.K. Murray, P.B. Clement, and R.H. Young Endometrioid carcinomas of the uterine corpus with sex cord-like formations, hyalinization, and other unusual morphologic features: a report of 31 cases of a neoplasm that may be confused with carcinosarcoma and other uterine neoplasms Am J Surg Pathol 29 2005 157 166 (Pubitemid 40170633)
27. K. Giehl Oncogenic RAS in tumour progression and metastases Biol Chem 386 2005 193 205 (Pubitemid 40485425)
28. M. Beeram, A. Patnaik, and E.K. Rowinsky Raf: a strategic target for therapeutic development against cancer J Clin Oncol 23 2005 6771 6790 (Pubitemid 46194105)
29. R.J. Kurman, and M. Shih Ie Ovarian low-grade and high-grade serous carcinoma: pathogenesis, clinicopathologic and molecular biologic features, and diagnostic problems Adv Anat Pathol 16 2009 267 282
30. K.K. Wong, Y.T. Tsang, and M.T. Deavers BRAF mutation is rare in advanced-stage low-grade ovarian serous carcinomas Am J Pathol 177 2010 1611 1617
31. K.R. Kim, J. Choi, and J.E. Hwang Endocervical-like (müllerian) mucinous borderline tumours of the ovary are frequently associated with the KRAS mutation Histopathology 57 2010 587 596
32. M.L. Gemignani, A.C. Schlaerth, and F. Bogomolniy Role of KRAS and BRAF gene mutations in mucinous ovarian carcinoma Gynecol Oncol 90 2003 378 381 (Pubitemid 36952030)
33. I.N. Mammas, A. Zafiropoulos, and D.A. Spandidos Involvement of the ras genes in female genital tract cancer Int J Oncol 26 2005 1241 1245
34. M. Cuatrecasas, N. Erill, and E. Musulen K-ras mutations in nonmucinous ovarian epithelial tumors. A molecular analysis and clinicopathologic study of 144 patients Cancer 82 1998 1088 1095 (Pubitemid 28136522)
35. R.F. Caduff, S.M. Svoboda-Newman, and A.W. Ferguson Comparison of mutations in Ki-RAS and p53 immunoreactivity in borderline and malignant epithelial ovarian tumors Am J Surg Pathol 23 1999 323 328 (Pubitemid 29117569)
36. T. Okuda, J. Otsuka, and A. Sekizawa p53 mutations and overexpression affect prognosis of ovarian endometrioid cancer but not clear cell cancer Gynecol Oncol 88 2003 318 325 (Pubitemid 36331984)
37. N.L. Sieben, P. Macropoulos, and G.M. Roemen In ovarian neoplasms, BRAF, but not KRAS, mutations are restricted to low-grade serous tumours J Pathol 202 2004 336 340 (Pubitemid 38325243)
38. D. Mayr, A. Hirschmann, and U. Lohrs KRAS and BRAF mutations in ovarian tumors: a comprehensive study of invasive carcinomas, borderline tumors and extraovarian implants Gynecol Oncol 103 2006 883 887 (Pubitemid 44821309)
39. I.K. Kolasa, A. Rembiszewska, and A. Janiec-Janowska PTEN mutation, expression and LOH at its locus in ovarian carcinomas. Relation to TP53, K-RAS and BRCA1 mutations Gynecol Oncol 103 2006 692 697 (Pubitemid 44602189)
40. V. Auner, G. Kriegshauser, and D. Tong KRAS mutation analysis in ovarian samples using a high sensitivity biochip assay BMC Cancer 9 2009 111
41. J.T. Geyer, M.A. Lopez-Garcia, and C. Sanchez-Estavez Pathogenetic pathways in ovarian endometrioid adenocarcinoma: a molecular study of 29 cases Am J Surg Pathol 33 2009 1157 1163
42. N. Nakayama, K. Nakayama, and S. Yeasmin KRAS or BRAF mutation status is a useful predictor of sensitivity to MEK inhibition in ovarian cancer Br J Cancer 99 2008 2020 2028
43. G. Singer, R. Oldt, and Y. Cohen Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma J Natl Cancer Instit 95 2003 484 486 (Pubitemid 36432423)
44. M. Ueda, E. Toji, and S. Noda Germ line and somatic mutations of BRAF V599E in ovarian carcinoma Int J Gynecol Cancer 17 2007 794 797 (Pubitemid 47063319)
45. D. Llobet, J. Pallares, and A. Yeramian Molecular pathology of endometrial carcinoma; practical aspects from the diagnostic and therapeutic viewpoints J Clin Pathol 62 2009 777 785
46. C.J.R. Stewart, B. Amanuel, and F. Grieu KRAS mutation and microsatellite instability in endometrial adenocarcinomas showing MELF-type myometrial invasion J Clin Pathol 63 2010 604 608
47. Y.Z. Feng, T. Shiozawa, and T. Miyamoto BRAF mutation in endometrial carcinoma and hyperplasia: correlation with KRAS and p53 mutations and mismatch repair protein expression Clin Cancer Res 11 2005 6133 6138 (Pubitemid 41262939)
48. T.A. Yap, C.P. Carden, and S.B. Kaye Beyond chemotherapy: targeted therapies in ovarian cancer Nat Rev Cancer 9 2009 167 181
49. E. Vakiani, and D.B. Solit KRAS and BRAF: drug targets and predictive biomarkers J Pathol 223 2011 219 229